Twist Bioscience Corporation (TWST) Prices 3.03M Share Common Offering at $33/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Twist Bioscience Announces Pricing of a $100 Million Public Offering of Common Stock
June 3, 2020 10:16 PM EDTSOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the pricing of an underwritten public offering of 3,030,303 shares of its common stock at a price to the public of $33.00 per share. The gross proceeds of the offering before deducting the underwriting discount and commissions and estimated offering expenses, and assuming no exercise of the underwriters option to purchase additional shares, are expected to be approximately $100 million. Twist has granted the... More



